Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Debt to Equity (2018 - 2025)

TransMedics (TMDX) has 8 years of Debt to Equity data on record, last reported at $0.13 in Q4 2025.

  • For Q4 2025, Debt to Equity fell 51.5% year-over-year to $0.13; the TTM value through Dec 2025 reached $0.13, down 51.5%, while the annual FY2025 figure was $0.13, 51.5% down from the prior year.
  • Debt to Equity reached $0.13 in Q4 2025 per TMDX's latest filing, down from $0.17 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.7 in Q2 2022 and bottomed at $0.13 in Q4 2025.
  • Average Debt to Equity over 5 years is $0.36, with a median of $0.33 recorded in 2021.
  • Peak YoY movement for Debt to Equity: surged 77.53% in 2022, then plummeted 51.5% in 2025.
  • A 5-year view of Debt to Equity shows it stood at $0.52 in 2021, then plummeted by 39.61% to $0.31 in 2022, then skyrocketed by 37.42% to $0.43 in 2023, then tumbled by 39.67% to $0.26 in 2024, then tumbled by 51.5% to $0.13 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt to Equity were $0.13 in Q4 2025, $0.17 in Q3 2025, and $0.19 in Q2 2025.